PDCD1 and colorectal cancer: During the anti-PD-1 treatments in colorectal cancer, its reactivity was impaired by a deubiquitinating enzyme USP14, which inhibited PD-1 expression and CD8+ T cell infiltration by targeting the IDO1/TRP/KYN signaling axis (Shi et al., 2022).